Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial

Yuan Zhang(Beijing Tongren Hospital), Luo Zhang(Hebei Medical University), Shaoqing Yu(Intelligent Health (United Kingdom)), Bing Yan(Kunming Children's Hospital), Jiping Li(University of Chinese Academy of Sciences), Lizhong Su(Beihang University), Lijia Wan(Yangtze University), Li Shi(Shandong University), Yucheng Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guolin Tan(Central South University), Shengyang Liu(Shandong University), Yi Yang(Zhejiang University), Bo Chen(Bioscience (China)), Jing Ye(Nanchang University), Jianjun Chen(Union Hospital), Feng Liu(Sichuan University), Jinfeng Liu(Capital Medical University), Wei Liu(Academy of Military Medical Sciences), Lin Wang(Inner Mongolia Agricultural University), Yu Zhang(Hefei University of Technology), Changqing Zhao(Shanxi Medical University), Hongyue Yan(Bioscience (China)), Yu Xu(Fujian Medical University), Shen Shen(Capital Medical University), Xicheng Song(Yuhuangding Hospital), Chengshuo Wang(Chinese Academy of Sciences), Luyun Jiang(Chengdu University of Traditional Chinese Medicine), Yan Jiang(Qingdao University)
EClinicalMedicine
July 1, 2023
Cited by 61


Related Papers